SCHEMBL5951383

SCHEMBL5951383

C[Sn](C)(C)c1ccc(N)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.50
MAPT P10636 2/20 0.50
KMT2A Q03164 2/20 0.50
ACHE P22303 1/20 0.45
TDP1 Q9NUW8 9/20 0.42
CYP3A4 P08684 8/20 0.42
ALDH1A1 P00352 7/20 0.42
TP53 P04637 2/20 0.42
MAPK1 P28482 4/20 0.39
ALOX15 P16050 3/20 0.39
HSD17B10 Q99714 2/20 0.38
CA3 P07451 1/20 0.38
THRB P10828 1/20 0.38
CA6 P23280 1/20 0.38
CASP1 P29466 1/20 0.38
HIF1A Q16665 1/20 0.38
CA14 Q9ULX7 1/20 0.38
TSHR P16473 5/20 0.36
GFER P55789 1/20 0.36
APP P05067 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1593230 0.83
SCHEMBL8585311 0.73 ALDH1A1 (0.32) TDP1CYP3A4ALDH1A1TP53
SCHEMBL904638 0.71 ACHE (0.53) ACHETDP1ALDH1A1TSHR
SCHEMBL320609 0.71 MEN1 (1.00) MEN1MAPTKMT2AACHETDP1
SCHEMBL27981 0.71
SCHEMBL11412373 0.69 TDP1 (0.43) MEN1MAPTKMT2AACHETDP1
SCHEMBL2392186 0.69 LMNA (0.50) MEN1KMT2ACYP3A4ALDH1A1TP53
SCHEMBL979413 0.69 ACHE (0.45) ACHEAPPLOXL2TAAR1
SCHEMBL5952745 0.69 CYP2A6 (0.50) TDP1ALDH1A1MAPK1ALOX15TSHR
SCHEMBL5951790 0.69 CYP3A4 (0.50) MEN1MAPTKMT2AACHECYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7038070-B2 Preparation of preparing substituted indanones BASELL POLYOLEFINE GMBH (DE) 2006-05-02 US disclosed
US-6963017-B2 Preparation of preparing substituted indanones BASELL POLYOLEFINE GMBH (DE) 2005-11-08 US disclosed
EP-0968158-B1 METHOD OF PREPARING SUBSTITUTED INDANONES, THE SUBSTITUTED INDANONES AND METALLOCENES PREPARED THEREFROM BASELL POLYOLEFINE GMBH (DE) 2005-08-10 EP disclosed
US-20050033076-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2005-02-10 US disclosed
US-20030009046-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2003-01-09 US disclosed
US-4977288-A M-aminophenyltrialkylstannane PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 1990-12-11 US disclosed
WO-1989007097-A1 RADIOHALOGENATED BIOTIN AND INTERMEDIATES THEREFOR PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 1989-08-10 WO disclosed
EP-0001717-B1 INSECTICIDAL COMPOSITIONS CONTAINING TETRAORGANOTIN COMPOUNDS AND METHOD FOR USING SAME M & T CHEMICALS, INC. (US) 1981-11-04 EP disclosed
US-4212885-A Insecticidal compositions containing certain tetraorganotin compounds and method for using same M&T CHEMICALS INC. (US) 1980-07-15 US disclosed
EP-0001717-A2 Insecticidal compositions containing tetraorganotin compounds and method for using same M & T CHEMICALS, INC. (US) 1979-05-02 EP disclosed
US-4138483-A Insecticidal compositions containing certain tetraorganotin compounds and method for using same M&T CHEMICALS INC. (US) 1979-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050033076-A1 Preparation of preparing substituted indanones CYP1A2, CYP2J2, IDH3A MEN1 718/4885MAPT 3693/4885KMT2A 3372/4885
US-20030009046-A1 Preparation of preparing substituted indanones CYP1A2, CYP1B1, CYP1A1 MEN1 614/4885MAPT 3748/4885KMT2A 3578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.